Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, People's Republic of China.
Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, People's Republic of China.
J Glob Antimicrob Resist. 2024 Jun;37:28-36. doi: 10.1016/j.jgar.2024.02.004. Epub 2024 Feb 25.
To analyse the clinical characteristics and risk factors for bloodstream infections (BSIs) caused by carbapenem-resistant Enterobacteriaceae (CRE) in neonates.
This single-centre, retrospective study included all patients with BSIs admitted to a neonatal intensive care unit between 1 January 2015 and 30 April 2022. The clinical and microbiological data of patients were collected; predictors of 30-day mortality in patients with CRE BSIs were also identified in this study.
Among the 224 neonates with Enterobacteriaceae BSIs, 39.29% (88/224) of the patients developed CRE BSIs. The 30-day mortality rate reached up to 21.59% (19/88). The Quick Sequential Organ Failure Assessment score > 2 (odds ratio [OR] and 95% credibility interval [CI]: 3.852 [1.111-13.356], P < 0.05), prior to more than two kinds of antibiotics use (OR and 95% CI: 9.433 [1.562-56.973], P < 0.05), pneumonia (OR and 95% CI: 3.847 [1.133-13.061], P < 0.05), and caesarean section (OR and 95% CI: 2.678 [1.225-5.857], P < 0.05) were independent risk factors associated with CRE BSIs. Moreover, the risk factors for mortality in neonates with CRE BSIs were significantly associated with neonatal Sequential Organ Failure Assessment score > 6 (OR and 95% CI: 16.335 [1.446-184.517], P < 0.05).
Prior to more than two kinds of antibiotics use, Quick Sequential Organ Failure Assessment score > 2, pneumonia and caesarean section were independent risk factors for CRE BSIs. The Neonatal Sequential Organ Failure Assessment score > 6 was a risk factor for mortality associated with CRE BSIs.
分析新生儿碳青霉烯类耐药肠杆菌科(CRE)血流感染(BSI)的临床特征和危险因素。
这是一项单中心、回顾性研究,纳入了 2015 年 1 月 1 日至 2022 年 4 月 30 日期间入住新生儿重症监护病房的所有 BSI 患者。收集患者的临床和微生物学数据;本研究还确定了 CRE BSI 患者 30 天死亡率的预测因素。
在 224 例肠杆菌科 BSI 患者中,39.29%(88/224)的患者发生了 CRE BSI。30 天死亡率高达 21.59%(19/88)。快速序贯器官衰竭评估(SOFA)评分>2(优势比[OR]和 95%可信区间[CI]:3.852[1.111-13.356],P<0.05)、使用超过两种抗生素之前(OR 和 95%CI:9.433[1.562-56.973],P<0.05)、肺炎(OR 和 95%CI:3.847[1.133-13.061],P<0.05)和剖宫产(OR 和 95%CI:2.678[1.225-5.857],P<0.05)是与 CRE BSI 相关的独立危险因素。此外,CRE BSI 新生儿死亡的危险因素与新生儿 SOFA 评分>6 显著相关(OR 和 95%CI:16.335[1.446-184.517],P<0.05)。
使用超过两种抗生素之前、SOFA 评分>2、肺炎和剖宫产是 CRE BSI 的独立危险因素。新生儿 SOFA 评分>6 是 CRE BSI 相关死亡率的危险因素。